Profile
Sector:
HealthcareIndustry:
Health Information ServicesCountry:
United StatesIPO:
28 November 2007Website:
http://www.optimizerx.comNext earnings report:
14 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Fri, 05 Jul 2024 20:02:31 GMTDividend
Analysts recommendations
Institutional Ownership
OPRX Latest News
OptimizeRx Corporation (NASDAQ:OPRX) Q1 2024 Earnings Conference Call on May 14, 2024 at 2:30 PM ET with Company Participants including CEO William Febbo, CFO Edward Stelmakh, President Steve Silvestro, and SVP of Corporate Finance Andrew D'Silva. Various conference call participants are also present. Thank you for joining the discussion on OptimizeRx's First Quarter Fiscal 2024 Earnings.
The average price target suggests a potential 34.8% increase for OptimizeRx (OPRX). Although studies show this metric may not always be accurate, an increase in earnings estimates could indicate a positive outlook for the stock in the short term.
WALTHAM, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a top provider of healthcare technology solutions assisting life sciences companies in connecting with healthcare professionals (HCPs) and patients, disclosed today that its management will be attending the following upcoming investor conferences:
WALTHAM, Mass., Feb. 21, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced that management will participate in the following upcoming investor conferences:
OptimizeRx Corp. (OPRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
OptimizeRx Corp. (OPRX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
OptimizeRx Corp. (OPRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
OptimizeRx Corporation. (NASDAQ:OPRX ) Q2 2023 Earnings Conference Call August 14, 2023 4:30 PM ET Company Participants William Febbo - Chief Executive Officer Edward Stelmakh - Chief Financial and Operating Officer Stephen Silvestro - Chief Commercial Officer Marion Odence-Ford - General Counsel and Chief Compliance Officer Andrew D'Silva - Senior Vice President, Corporate Finance Conference Call Participants Ryan Daniels - William Blair Sean Dodge - RBC Capital Markets Eric Martinuzzi - Lake Street Operator Good afternoon, everyone.
ROCHESTER, Mich., July 31, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy will hold a conference call on Monday, August 14, 2023 at 4:30 p.m. Eastern Time to discuss its results for the second quarter and half year period ended June 30, 2023. The financial results will be issued in a press release prior to the call.
OptimizeRx Corporation provides communication technologies between pharma firms, healthcare providers, and patients. The company has seen material operating headwinds as the U.S. healthcare industry exited the pandemic and FDA approvals slowed. Until we see improving operating metrics and faster FDA approvals, I'm Neutral [Hold] on OptimizeRx Corporation.
What type of business is OptimizeRx?
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys. Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was found in 2006 and is headquartered in Rochester, Michigan.
What sector is OptimizeRx in?
OptimizeRx is in the Healthcare sector
What industry is OptimizeRx in?
OptimizeRx is in the Health Information Services industry
What country is OptimizeRx from?
OptimizeRx is headquartered in United States
When did OptimizeRx go public?
OptimizeRx initial public offering (IPO) was on 28 November 2007
What is OptimizeRx website?
https://www.optimizerx.com
Is OptimizeRx in the S&P 500?
No, OptimizeRx is not included in the S&P 500 index
Is OptimizeRx in the NASDAQ 100?
No, OptimizeRx is not included in the NASDAQ 100 index
Is OptimizeRx in the Dow Jones?
No, OptimizeRx is not included in the Dow Jones index
When does OptimizeRx report earnings?
The next expected earnings date for OptimizeRx is 14 August 2024